Standstill in urology business will cost Coloplast DKK 100 million a month
Coloplast expects a difficult third quarter, particularly due to the fact that elective operations, for example those involving penis implant Titan, have been cancelled. That will cost DKK 100 million (USD 14.4 million) a month in lost revenue just within urology, says the firm's financial director.
BY KEVIN GRØNNEMANN, TRANSLATED BY CATHERINE BRETT
Despite good reports from the first two quarters of Coloplast's financial year 2019/2020, the company is preparing itself for a bad third quarter, where the coronavirus pandemic will make itself felt on the company's revenue.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
